Contact
Mary Ann NicholsVanderbilt University
medical.education@vanderbilt.edu
615-936-8555
Where
208 Light HallThursday, June 7, 2012
Medical Education Grand Rounds
"Lessons Learned in the Assessment of Professional Competence"
Cees van der Vleuten, Ph.D.
Department of Educational Development and Research
University of Maastricht
The Netherlands
Cees van der Vleuten came to the University of Maastricht in 1982. He was appointed as a Professor of Education in 1996 at the Faculty of Health, Medicine and Life Sciences and chair of the Department of Educational Development and Research. In 2005 he was appointed as the Scientific Director of the School of Health Professions Education (www.she.unimaas.nl). His area of expertise lies in evaluation and assessment. He has published widely on these topics, holds numerous academic awards for his work, including several career awards. He has frequently served as a consultant internationally. He is a mentor for many researchers in medical education and has completed about 50 doctoral graduate students in the past. In 2010 he received a Dutch royal decoration for the societal impact of his work. A full curriculum vitae can be found at: http://www.fdg.unimaas.nl/educ/cees/CV/CV%20Cees.pdf
Sponsored by Vanderbilt University School of Medicine; Department of Office of Teaching and Learning in Medicine.
Vanderbilt University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vanderbilt School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. It is the policy of the ACCME and Vanderbilt University School of Medicine to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity. Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.
